NCT00156377View on ClinicalTrials.gov

Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

November 30, 2002

Conditions
Cross InfectionStaphylococcal Infections
Interventions
DRUG

Mupirocin

Trial Locations (1)

48149

Institute of Medical Microbiology, University Hospital of Muenster, Münster

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University Hospital Muenster

OTHER